Role of Prostaglandin Analogs in The Treatment of Glaucoma
description
Transcript of Role of Prostaglandin Analogs in The Treatment of Glaucoma
![Page 1: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/1.jpg)
Role of Prostaglandin Role of Prostaglandin Analogs in The Treatment Analogs in The Treatment
of Glaucomaof Glaucoma
Mahmood J Showail MD
![Page 2: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/2.jpg)
GlaucomaGlaucoma
One of the most common cause of blindness in the world.
![Page 3: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/3.jpg)
Glaucoma
Glaucoma is characterized by three factors:• Elevated Intra Ocular
Pressure (IOP)
• Optic nerve damage
(cupping of the disc)
• Progressive loss of
visual field
![Page 4: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/4.jpg)
Visu
al F
ield
Los
s
Intraocular Pressure
Optic Nerve Dam
age
Glaucoma
![Page 5: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/5.jpg)
Glaucoma
Mechanisms of aqueous humor
Aqueous is produced by the ciliary processes
It flows into the posterior chamber
Bathes the lens
Fills the anterior chamber
![Page 6: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/6.jpg)
Glaucoma
Aqueous Flow Dynamics
Inflow should be equal to the outflow
Normal IOP is between 10 – 20 mmHg
Normally the IOP is highest in the morning and lowest in the evening• Diurnal curve
![Page 7: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/7.jpg)
There are two major component of aqueous outflow :
• Trabecular outflow “pressure dependant” • Uveoscleral outflow “pressure independant”
Aqueous Humor Outflow
![Page 8: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/8.jpg)
Trabecular Outflow Most of the aqueous exits the eye through
trabecular meshwork- schlemm’s canal- venous system
The TM can be devided into three zones• Uveal • Corneoscleral• Juxtacanalicular
The primary resistance occurs at the juxtacanalicular tissue.
![Page 9: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/9.jpg)
![Page 10: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/10.jpg)
Anatomy ReviewAnatomy Review
![Page 11: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/11.jpg)
![Page 12: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/12.jpg)
The TM functions as a one way valve that permits aqueous to leave the eye by bulk flow .
Once in schlemm’s canal, aqueous enter the episcleral veinous plexus by way of scleral collector channels.
![Page 13: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/13.jpg)
Uveoscleral Outflow
The aqueous passages from the anterior chamber into the cilliary muscle and then into the supracilliary and suprachoroidal spaces.
The fluid then exits the eye through the intact sclera or along the nerves and the vessels that penetrate it.
![Page 14: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/14.jpg)
![Page 15: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/15.jpg)
Uveoscleral Outflow
Uveoscleral outflow is pressure independent and is believed to be influnced by age.
Recent researches suggest that it may be a more important route of aqueous outflow than previously thought . Possibly accounting for up to 50% in normal eyes of young people.
![Page 16: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/16.jpg)
Aqueous Humor Outflow
The facililty of outflow “C in goldman equation”varies widely in normal eyes
The mean value reported from 0.22 to 0.28 µl/min/mmHg
Outflow facililty decrease with age & is affected by surgery, trauma, medications and endocrine factors
Patients with glaucoma and elevated IOP have decreased outflow facililty
![Page 17: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/17.jpg)
Goldman equationPº = (F/C) + Pv
• Pº IOP in “mmHg”• F rate of aqueous formation “µl/min”• C facililty of outflow “µl/min/mmHg”• Pv episcleral venous pressure “mmHg”
![Page 18: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/18.jpg)
How would we decrease the pressure?
![Page 19: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/19.jpg)
Glaucoma
Decrease the IOP in Glaucoma
Decrease the inflow• Blocking the mechanism of production
Increase the outflow• Through the trabecular meshwork• Through the uveoscleral channels
![Page 20: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/20.jpg)
Prostaglandin Analogs
![Page 21: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/21.jpg)
Prostaglandins Analogs
• Latanaprost (Xalathan)• Bimatoprost (Lumigan)• Travoprost (Travatan)
Side effects:
Iris pigmentation and irritation/redness
![Page 22: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/22.jpg)
• Prostaglandin + Betablockers– Decrease production of aqueous humor
• (double effectiveness)• Generics
– Latanoprost +
Timolol (0.005% with 0.5% solution)
• Usage:– Once daily in the morning
Glaucoma Drugs
Combination Drugs
• Brands– Xalacom
![Page 23: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/23.jpg)
Xalacom
Careful medical history is important Notify the doctor if the patient suffers
from:• Asthma• Heart disease• Diabetes• Hypoglycemia• Overactive thyroid gland• Hypotension• Vascular disorders
![Page 24: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/24.jpg)
So, How would Prostaglandin analogs
works??
![Page 25: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/25.jpg)
Prostaglandin analogues lower intraocular pressure by increasing uveoscleral outflow.
Although the precise mechanism is not clearly understood, there appears to be activation of a molecular transduction cascade and increase in the biosynthesis of metalloproteneases ( MMP-1, MMP-2& MMP9).
This lead to reduction of extracellular matrix components within the cilliary muscle, iris root and sclera
![Page 26: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/26.jpg)
Uveoscleral out flow is known to flow from the anterior chamber into the extracellular spaces of the ciliary muscle and then in large part pass through sclera.
Hence, It is possible that reduction of ECM and widening and decompressing the connective tissue that is present within portions of the uveoscleral pathway may contribute to the mechanism of ↑↑ outflow.
![Page 27: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/27.jpg)
![Page 28: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/28.jpg)
Additional mechanisms that may contribute to PG mediated increase of uveoscleral outflow include
• Relaxation of ciliary muscle and widening of intermuscular spaces.
• Cell shape changes• Cytoskeletal alteration • Compaction of the ECM within the tissue of
the uveoscleral outflow pathway .
![Page 29: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/29.jpg)
Many study have reported that PGF2α and its analouges and prodrugs can increrase total outflow facility in monkeys and human ( a comination of trabecular, uveoscleral and pseudo- facililty )
less consistent finding is an increase in trabecular outflow facility “ with a lot of controversies”.
![Page 30: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/30.jpg)
Trabecular outflow facility is not always increased following topical treatment with PG analogs but evidence is building that the effect is real and not unique to any one drug of this class.
Latanoprost, travoprost, bimatoprost, and unoprostone all have been found to significantly increase trabecular outflow facility in at least one clinical study*
* Update on the Mechanism of Action of Topical Prostaglandins for Intraocular Pressure Reduction doi:10.1016/j.survophthal.2008.08.010
![Page 31: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/31.jpg)
Latanoprost (Xalatan)
Latanoprost is a prostaglandin F2α analogue. Its chemical name is isopropyl - (Z) -7 [(1R,2R,3R,5S) 3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl] cyclopentyl] -5-heptenoate.
Its molecular formula is C26 H40 O5 and its chemical structure is:
![Page 32: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/32.jpg)
Latanoprost is a colorless to slightly yellow oil & Benzalkonium chloride, 0.02% is added as a preservative.
![Page 33: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/33.jpg)
Action:• Reduce IOP by increasing the outflow through
uveoscleral channels
• Lowers IOP in 3- 4 hrs after instillation
Generics• Latanaprost (0.005% Sol.)
Usage:• Once daily at bedtime
Brands• Xalatan
Glaucoma Drugs
Prostaglandin Analogs
![Page 34: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/34.jpg)
![Page 35: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/35.jpg)
Bimatoprost (LUMIGAN)
Bimatoprost, an amide that is classified as a prostamide, ( so it is not a prostaglandin but it acts on FP prostanoid receptor)
The free acid of bimatoprost is identical to that of latanoprost with exception of a double instead of a single bond at the carbon13-14 position
![Page 36: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/36.jpg)
![Page 37: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/37.jpg)
The free acid of bimatoprost is known to be a very potent FP receptor agonist
The hydrolysis of bimatoprost have been demonstrated in human corneal tissue in vitro.
Enzymes including amidases,peptidases and fatty acid amide hydrolases capable of hydrolysing bimatoprost to its free acid and activate FP prostanoid receptor
![Page 38: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/38.jpg)
Bimatoprost appears to reduce the IOP of patients who are unresponsive to latanoprost.
suggesting that the prostamide bimatoprost and the FP
receptor agonist latanoprost stimulate different receptor populations.
This is consistent with studies on isolated iridial cells where bimatoprost stimulated an entirely different cell population to those sensitive to PGF2α and bimatoprost acid .
An equally plausible explanation is that some eyes may be deficient in corneal esterase and thus are not able to adequately convert the prodrug latanoprost into its free acid active form.
![Page 39: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/39.jpg)
• Action:– Reduce IOP by increasing the outflow through
uveoscleral channels
• Generics– Bimatoprost (0.03% Sol.)
• Usage:– Once daily at bedtime– Should NOT be used under 18 yrs of age.
• Brands– Lumigan
Glaucoma Drugs
Prostaglandin Analogs
![Page 40: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/40.jpg)
Travoprost (TRAVATAN)
Travoprost is a PGF2α analog, is an isopropyl ester of the enantiomer of fluprostenol.
It is structurally similar to other f2α anlogs.
It is a selective FP prostanoid receptor agonist.
![Page 41: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/41.jpg)
![Page 42: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/42.jpg)
• Action:– Reduce IOP by increasing the outflow through
uveoscleral channels
– Lowers IOP in 2 - 3 hrs after instillation
Generics– Travoprost (0.004% Sol.)
• Usage:– Once daily at bedtime
Brands–Travatan
Glaucoma Drugs
Prostaglandin Analogs
![Page 43: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/43.jpg)
![Page 44: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/44.jpg)
Pharmacokinetics
Reduction of the intraocular pressure starts approximately 3 to 4 hours after administration and the maximum effect is reached after 8 to 12 hours.
XALATAN may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart
![Page 45: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/45.jpg)
Absorption: Latanoprost is absorbed through the cornea where the isopropyl ester prodrug is hydrolyzed to the acid form to become biologically active.
Studies in man indicate that the peak concentration in the aqueous humor is reached about 2 hours after topical administration.
![Page 46: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/46.jpg)
Pediatric Use: Safety and effectiveness in pediatric patients have not been established.
![Page 47: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/47.jpg)
CONTRAINDICATIONS
XALATAN has been reported to cause changes to pigmented tissues. The most frequently reported changes have been increased pigmentation of the iris and periorbital tissue (eyelid) and increased pigmentation and growth of eyelashes.
These changes may be permanent.
![Page 48: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/48.jpg)
WARNINGS / PRECAUTIONS Concerns related to adverse effects:
Bacterial keratitis: Inadvertent contamination of multiple-dose ophthalmic solutions, has caused bacterial keratitis.
Ocular effects: May permanently change/increase brown pigmentation of the iris, the eyelid skin, and eyelashes. In addition, may increase the length and/or number of eyelashes (may vary between eyes); changes occur slowly and may not be noticeable for months or years. Long-term consequences and potential injury to eye are not known.
![Page 49: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/49.jpg)
ADVERSE REACTIONS SIGNIFICANT
>10%: Ocular: Blurred vision, burning and stinging, conjunctival hyperemia, foreign body sensation, itching, increased pigmentation of the iris, and punctate epithelial keratopathy
![Page 50: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/50.jpg)
1% to 10%: Cardiovascular: Chest pain, angina pectoris Dermatologic: Rash, allergic skin reaction Neuromuscular & skeletal: Myalgia, arthralgia, back pain Ocular: Dry eye, excessive tearing, eye pain, lid crusting, lid edema, lid erythema, lid discomfort/pain, photophobia Respiratory: Upper respiratory tract infection, cold, flu
![Page 51: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/51.jpg)
Ocular:• Change in iris
color• Burning• Stinging• Decreased VA• Sensitivity to light• Pain • Hyperemia
Systemic:• Headaches
Summary – Common Side Effects
Prostaglandin Analogs
![Page 52: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/52.jpg)
DRUG INTERACTIONS Bimatoprost: The concomitant use of Latanoprost and Bimatoprost may result in increased intraocular pressure. Risk D: Consider therapy modification
![Page 53: Role of Prostaglandin Analogs in The Treatment of Glaucoma](https://reader035.fdocuments.net/reader035/viewer/2022062809/5681598c550346895dc6d40d/html5/thumbnails/53.jpg)
Thank You
..